- Research works
- 79 ▼ 79% vs 2013–17
- Citations
- 3.5k 43.7 per fractional work
- Top-10% rate
- 6.7% record average 16.5%
- Open access
- 41% world 28%
Not ranked overall: MolMed (Italy) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Who are the top researchers at MolMed (Italy)?
Ranked on the composite score, Catia Traversari lead among researchers whose main affiliation is MolMed (Italy).
- 1 Catia Traversari Italy · #1,026,153 worldwide 49 citations · 25 works
Which keywords describe research at MolMed (Italy)?
By fractional works in all years, weighted toward what it does more of than the world: Immunotherapy, Gene Therapy, Cancer Immunotherapy, Genomic Integration, AAV, Viral Vectors, Tumor Regression and Cancer Therapy.
- Congenital Infection
- RNA Interference
- Infection
- Clinical Trials
- Transplant Recipients
- Mammalian Cells
- Targeted Therapy
- Prognostic Factors
- Monoclonal Antibody
- NK Cell Recognition
- Glycosylation
- Fibroblast Activation Protein
- PET Imaging
- Tumor Microenvironment
- Leukemia
- CAR T Cells
- Cancer Therapy
- Viral Vectors
- Genomic Integration
- Gene Therapy
- Immunotherapy
- Cancer Immunotherapy
- AAV
- Tumor Regression
- Lymphoma
- Chimeric Antigen Receptor
- Angiogenesis
- Immunosuppression
- Stromal Cells
- N-terminal Acetylation
- Chemotherapy
- Natural Killer Cells
- Biopharmaceutical Production
- Cell Culture
- Hematopoietic Stem Cells
- Recombinant Protein
- Antiretroviral Therapy
- Metastasis
- Immunity
- siRNA Delivery
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Immunotherapy13▲ 25×10 topics
- Gene Therapy12▲ 58×3 topics
- Cancer Immunotherapy9▲ 82×2 topics
- Genomic Integration9▲ 106×2 topics
- AAV9▲ 166×1 topic
- Viral Vectors9▲ 166×1 topic
- Tumor Regression8▲ 115×2 topics
- Cancer Therapy7▲ 14×7 topics
- Lymphoma7▲ 61×3 topics
- CAR T Cells7▲ 203×1 topic
- Chimeric Antigen Receptor7▲ 203×1 topic
- Leukemia7▲ 135×2 topics
- Angiogenesis7▲ 21×5 topics
- Tumor Microenvironment7▲ 23×5 topics
- Immunosuppression6▲ 66×3 topics
- PET Imaging6▲ 32×3 topics
- Stromal Cells5▲ 74×2 topics
- Fibroblast Activation Protein5▲ 129×1 topic
- N-terminal Acetylation5▲ 129×1 topic
- Glycosylation5▲ 26×3 topics
- Chemotherapy4▲ 8.1×11 topics
- NK Cell Recognition4▲ 48×1 topic
- Natural Killer Cells4▲ 48×1 topic
- Monoclonal Antibody4▲ 67×2 topics
- Biopharmaceutical Production4▲ 57×2 topics
- Prognostic Factors4▲ 9.7×5 topics
- Cell Culture3▲ 39×2 topics
- Targeted Therapy3▲ 20×5 topics
- Hematopoietic Stem Cells3▲ 41×3 topics
- Mammalian Cells3▲ 107×1 topic
- Recombinant Protein3▲ 107×1 topic
- Transplant Recipients3▲ 49×2 topics
- Antiretroviral Therapy3▲ 17×3 topics
- Clinical Trials3▲ 6.5×4 topics
- Metastasis3▲ 11×4 topics
- Infection3▲ 13×3 topics
- Immunity3▲ 10×4 topics
- RNA Interference3▲ 30×1 topic
- siRNA Delivery3▲ 45×1 topic
- Congenital Infection3▲ 71×1 topic
Which research topics does MolMed (Italy) publish most on?
By volume in 2022–2025: Immune cells in cancer, Inflammation biomarkers and pathways, Simulation Techniques and Applications and Robotic Path Planning Algorithms.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Immune cells in cancer Immunology 0 works
- 2 Inflammation biomarkers and pathways Immunology 0 works
- 3 Simulation Techniques and Applications Management Science and Operations Research 0 works
- 4 Robotic Path Planning Algorithms Computer Vision and Pattern Recognition 0 works
- 5 Reinforcement Learning in Robotics Artificial Intelligence 0 works
- 6 Cholesterol and Lipid Metabolism Surgery 0 works
- 7 Immunotherapy and Immune Responses Immunology 0 works
- 8 Immune Cell Function and Interaction Immunology 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has MolMed (Italy)'s research output changed?
Output in 2018–2022 was 79% lower than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Milan
- University of Milan
- Politecnico di Milano
- Università Cattolica del Sacro Cuore
- University of Milano-Bicocca
- Vita-Salute San Raffaele University
- Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico
- Fondazione IRCCS Istituto Nazionale dei Tumori
- Mario Negri Institute for Pharmacological Research
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.